Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Hurricane Verge Sandal Pine Needle Release Info | Hypebeast
Teva shares surge after announcing global opioid settlement
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
$300 million Teva bet: Will Norway's wealth fund and ION regret investing in the phar | Ctech
Secretariat Economists Assists DOJ in Securing Record-Breaking $305M Settlement Deal in Teva/Glenmark Generic Drugs Price-Fixing Case - Secretariat Economists
Teva Pharmaceuticals (@TevaUSA) / X
Watch CNBC's full interview with Teva CEO Richard Francis - YouTube
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Hurricane Verge Sandal Pine Needle Release Info | Hypebeast
BCBS Vermont suing Teva Pharmaceuticals over MS drug marketing | Healthcare Finance News
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Forecasts Growth After Expected Actavis Deal Closes | Stock News & Stock Market Analysis - IBD
The best Teva sandals to wear this summer
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva Defeats Patent Infringement Claims on Endocrine Drug | ...
Teva seeks CEO replacement as Shultz will retire in 2023: WSJ
Here's Why Teva Pharma Stock Is Soaring Today
Tel Aviv-based Teva CEO: Our manufacturing is unaffected as it stands
Teva CEO Sounds Off
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
